Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evolution of plasma hepatitis C virus load in patients coinfected by HIV and hepatitis C Virus started on a protease inhibitor-containing antiretroviral regimen, Agence Nationale de Recherches sur le SIDA CO8 APROCO-COPILOTE cohort.
Neau D, Trimoulet P, Pereira E, Lafon ME, Gervais A, Ragnaud JM, Dupon M, Ecobichon JL, Chêne G, Raffi F; ANRS CO8 APROCO-COPILOTE Study Group. Neau D, et al. J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):227-9. doi: 10.1097/QAI.0b013e31816d9cc3. J Acquir Immune Defic Syndr. 2008. PMID: 18520685 No abstract available.
CD4 T lymphocyte proliferative responses to hepatitis C virus (HCV) antigens in patients coinfected with HCV and human immunodeficiency virus who responded to anti-HCV treatment.
Legrand E, Neau D, Galperine T, Trimoulet P, Moreau JF, Pitard V, Lacut JY, Ragnaud JM, Dupon M, Le Bail B, Bernard N, Schvoerer E, Houghton M, Fleury H, Lafon ME. Legrand E, et al. Among authors: neau d. J Infect Dis. 2002 Aug 1;186(3):302-11. doi: 10.1086/341659. Epub 2002 Jul 17. J Infect Dis. 2002. PMID: 12134226 Clinical Trial.
Human immunodeficiency virus type 1 genotypic and pharmacokinetic determinants of the virological response to lopinavir-ritonavir-containing therapy in protease inhibitor-experienced patients.
Masquelier B, Breilh D, Neau D, Lawson-Ayayi S, Lavignolle V, Ragnaud JM, Dupon M, Morlat P, Dabis F, Fleury H; Groupe d' Epidémiologie Clinique du SIDA en Aquitaine. Masquelier B, et al. Among authors: neau d. Antimicrob Agents Chemother. 2002 Sep;46(9):2926-32. doi: 10.1128/AAC.46.9.2926-2932.2002. Antimicrob Agents Chemother. 2002. PMID: 12183249 Free PMC article. Clinical Trial.
Time-updated CD4+ T lymphocyte count and HIV RNA as major markers of disease progression in naive HIV-1-infected patients treated with a highly active antiretroviral therapy: the Aquitaine cohort, 1996-2001.
Thiébaut R, Chêne G, Jacqmin-Gadda H, Morlat P, Mercié P, Dupon M, Neau D, Ramaroson H, Dabis F, Salamon R; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. Thiébaut R, et al. Among authors: neau d. J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):380-6. doi: 10.1097/00126334-200307010-00013. J Acquir Immune Defic Syndr. 2003. PMID: 12843750
Borna disease virus RNA in immunocompromised patients in southwestern France.
Cotto E, Neau D, Cransac-Neau M, Auriacombe M, Pellegrin JL, Ragnaud JM, Fillet AM, Belnard M, Fleury H, Lafon ME. Cotto E, et al. Among authors: neau d. J Clin Microbiol. 2003 Dec;41(12):5577-81. doi: 10.1128/JCM.41.12.5577-5581.2003. J Clin Microbiol. 2003. PMID: 14662943 Free PMC article.
346 results